(Q66886915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

Effect of aprotinin, EACA and heparin on growth and vasopeptide system of Murphy-Sturm lymphosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

Effect of apotinin, EACA and heparin on growth and vasopeptide system of murphy—sturm lymphosarcoma (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

7 September 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

7 September 2023

author name string

N. Back

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085254

20 August 2022

R. Steger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1085254

20 August 2022

language of work or name

English

0 references

publication date

1 August 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

https://api.elsevier.com/content/article/PII:0014299976903344?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

https://api.elsevier.com/content/article/PII:0014299976903344?httpAccept=text/plain

7 September 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

European Journal of Pharmacology

7 September 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

313-319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

Studies on the mechanism of action of inhibitors of the fibrinolysin system.

31 August 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Effect of inhibitors on kinin-releasing activity of proteases

7 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Kinin-Forming Activity of Cultured Mouse Fibroblasts L-929

7 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Low molecular weight organic acids as inhibitors of kinin-forming activity of a rodent tumor acid protease and human plasma kallikrein

7 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Release of fibrinolytic activators from human tumours cultured in vitro

7 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Plasminogen-activator-producing Tumour

7 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Effects of protease inhibitors on growth of hamster tumor cells in culture

7 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

The leukokinin system; its role in fluid accumulation in malignancy and inflammation.

7 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes

7 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Anti-tumour Activity of Aprotinin

7 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Proteases During the Growth of Ehrlich Ascites Tumor. II. The KallikreinKinin System23

7 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Proteases During the Growth of Ehrlich Ascites Tumor. II. The KallikreinKinin System23

7 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Properties of plasminogen activators formed by neoplastic human cell cultures

7 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Selective inhibition of growth of transformed cells by protease inhibitors

7 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Protease inhibitors do not block transformed cells in the G1 phase of the cell cycle.

7 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Tumorigenesis in Mouse Skin: Inhibition by Synthetic Inhibitors of Proteases

7 September 2023

33

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses

7 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

The inhibitory effect of alpha-2-macroglobulin on tumor growth

7 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

Effect of a protease inhibitor on the adhesion of Ehrlich ascites cells to host cells in vivo

7 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0014-2999(76)90334-4

7 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1085254%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference